The effects of the angiotensin receptor–neprilysin inhibitor sacubitril/valsartan (Sac/Val) on blood pressure (BP) and proteinuria in patients with advanced chronic kidney disease and hypertension remain unclear. The gene discussed is MME; the disease is chronic kidney disease.